Aqr Capital Management LLC Cor Medix Inc. Transaction History

Aqr Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.08 - $6.39 $51,575 - $80,775	-12,641 Reduced 53.05%	11,189 $48,000
Q1 2024 May 15, 2024	SELL	$2.94 - $4.24 $33,880 - $48,861	-11,524 Reduced 32.6%	23,830 $101,000
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $59,307 - $79,273	19,769 Added 126.85%	35,354 $132,000
Q3 2023 Nov 14, 2023	BUY	$3.6 - $4.46 $56,106 - $69,509	15,585 New	15,585 $57,000
Q1 2020 May 15, 2020	SELL	$2.35 - $7.08 $35,198 - $106,044	-14,978 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$4.96 - $7.75 $39,908 - $62,356	-8,046 Reduced 34.95%	14,978 $109,000
Q3 2019 Nov 14, 2019	BUY	$6.38 - $9.69 $146,893 - $223,102	23,024 New	23,024 $147,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.